Interferon - Idenix Provides Update on Clinical Development of Valopicitabine (NM283) for the Treatment of Hepatitis C

Idenix Provides Update on Clinical Development of Valopicitabine (NM283) for the Treatment of Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Mar 23 2:01 PM
Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases, announced today an update on its clinical development program for valopicitabine for the treatment of hepatitis C.Save to My Web

Carol G. Gallagher, Pharm. D., To Join Anadys Pharmaceuticals As Vice President, Commercial Affairs
RedNova - Mar 22 7:30 AM
SAN DIEGO, March 22 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. announced today the hiring of Carol G. Gallagher, Pharm. D., as Vice President, Commercial Affairs. Dr.Save to My Web

4th Monico cup drawing of lots scheduled today
Sun Star - Mar 17 8:57 PM
THE bracketing of teams in both the 19-Under and 26-Under divisions of the 4th Monico Cup Inter-Barangay Summer Basketball tournament goes on Saturday as scheduled, 2 p.m. at the residence of Bacolod City Representative Monico 0. Puentevella.Save to My Web

ViroPharma Announces Positive Phase 2 Results Demonstrating That Maribavir Significantly Reduces CMV Reactivation
FinanzNachrichten - Mar 29 5:22 PM
EXTON, Pa., March 29 /PRNewswire-FirstCall/ -- ViroPharma Incorporated ( Nachrichten ) today announced positive preliminary results from a Phase 2 study with maribavir, an oral antiviral drug candidate currently being developed to inhibit cytomegalovirus (CMV) reactivation in transplant patients.Save to My Web

ViroPharma Further Comments on Vancocin
Boursorama - Mar 17 1:12 PM
EXTON, Pa., March 17 /PRNewswire-FirstCall/ -- ViroPharma Incorporated today filed a Petition for Stay of Action with the FDA regarding the requirements for waivers of in-vivo bioequivalence testing for Vancocin.Save to My Web

Pharmaceutical and Biotechnology Companies Are Increasingly Shifting Their Drug Development for Infectious Diseases
[Press Release] Business Wire via Yahoo! Finance - Mar 23 4:05 AM
DUBLIN, Ireland----March 23, 2006--Research and Markets has announced the addition of the Decision Resources report "Emerging Antiviral Drug Targets" to their offeringSave to My Web

Morgan & Finnegan is First Intellectual Property Firm to Open a Shanghai Office
[Press Release] Business Wire via Yahoo! Finance - Mar 16 6:00 AM
NEW YORK----March 16, 2006--Morgan & Finnegan, L.L.P., one of the oldest and most successful intellectual property law firms, has opened an office in Shanghai, China. The office is staffed by two partners, Maria C.H.Save to My Web